Business is booming.

J&J Single-Shot Vaccine Safe in Early Trials: Report

Johnson & Johnson’s  (JNJ) – Get Report single-shot vaccine candidate has been shown to be safe and to generate a meaningful immune response in an early phase trial, according to a published report Wednesday.

Source link

Leave A Reply

Your email address will not be published.